Senegal Makes Affordable Sickle Cell Drug for 8M Patients

A Senegalese lab is producing Africa's first locally made sickle cell treatment at one-third the cost of imported drugs.

The breakthrough offers hope to 8 million patients worldwide, 80% of them in Africa.